Finding the one: How to choose a Clinical Partner in Sea of Service Providers
Publié le
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical…
Integration of Biomarker Validation in Clinical Development in Oncology
Publié le
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology….
THE IMPACT OF COVID-19 ON RANDOMIZED CLINICAL TRIALS
Publié le
The COVID-19 pandemic has a major impact on the conduct of most on-going clinical trials, in particular on the treatment…
The Impact of COVID-19 on Randomized Clinical Trials
Publié le
IMPACT OF COVID-19 on Clinical Trials: LEARN ON OPERATIONAL CHALLENGES TO CONSIDER, ESPECIALLY RELATED TO MISSING DATA AND PROTOCOL DEVIATIONS …
IDDI in Contract Pharma
Publié le
Insight on the pharma and biopharma trends impacting CROs, Outsourcing in today’s market, and advances in clinical research. READ IDDI…
Biostatistics & Data Management: combined services ensuring you meet your study goals!
Publié le
Today’s session is focusing on the key clinical trial services of data management & biostatistics, and considerations for why there…
Podcast: IDDI Services
Publié le
Listen to IDDI Podcast on IDDI Services Vicky Martin, Sr Business Director US , IDDI Learn more on IDDI…
Webinar: Minimization: A Flexible Randomization Method
Publié le
IDDI Complimentary Webinar on Minimization LEARN ON: Minimization method including demonstration of some of the advantages of minimization over permuted…
Surrogate endpoints create potential, require statistical validation
Publié le
Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the…
Using disease free survival as a primary endpoint in early breast cancer
Publié le
IDDI in collaboration with Roche have identified why using disease-free survival as a primary endpoint in early breast cancer is…